Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00277589
Status:
COMPLETED
Last Update Posted:
2009-12-04
First Post:
2006-01-13
Brief Title:
LISA-study Levothyroxin in Nodular Goiter
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
TSH-adapted Therapy in a Large Randomized Observer-blind Placebo-controlled Prospective Treatment Study of Patients With Nodular Goiter
Status:
COMPLETED
Status Verified Date:
2009-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Primary objective
To evaluate change in total volume of all nodules
Secondary objectives
To evaluate change in goiter volume after a 12-months treatment number of nodules and echogenicity of nodules
To evaluate change in total volume of all nodules
Secondary objectives
To evaluate change in goiter volume after a 12-months treatment number of nodules and echogenicity of nodules
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None